Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. Equipment
  3. germany
  4. immunotherapy treatment
Show results for
Products
Services

Companies


Refine by
Locations
Back to All Locations

  • Europe
  • Germany
Brands

  • cellgenix
  • oncimmune serotag
  • tafasitamab

Immunotherapy Treatment Equipment Supplied In Germany

4 equipment items found
In GermanyAvailable In GermanyNear Germany

Oncolytic Virotherapy

Oncolytic Virotherapy

by:Fusix Biotech   based inMünchen, GERMANY
As multi-mechanistic antitumor agents, oncolytic viruses are emerging to be potent immunotherapeutic treatment options in different tumor indications. Oncoytic viruses specifically replicate in tumor cells due to altered signalling pathways supporting the tumor’s immune esape, leaving open replication advantages for viruses susceptible to intact signaling pathways. ...
CONTACT SUPPLIER

CellGenix - Model GMP DC - Medium Dendritic Cell

CellGenix - Model GMP DC - Medium Dendritic Cell

Manufactured by:Sartorius CellGenix GmbH   based inFreiburg, GERMANY
CellGenix GMP DC is an optimized, serum-free medium used for the generation of human dendritic cells (DCs). It promotes high yields of mature dendritic cells with the desired ...
CONTACT SUPPLIER

Oncimmune SeroTag - Discovery Technology

Oncimmune SeroTag - Discovery Technology

by:Oncimmune Holdings PLC   based inNottingham, UNITED KINGDOM
Oncimmune’s proprietary biomarker discovery engine, which is leveraged in our ImmunoINSIGHTS services to discover and validate novel biomarkers that can help stratify patients in multiple cancer indications and with different autoimmune ...
CONTACT SUPPLIER

Tafasitamab - Model MOR208 - Humanized FC-Modified CD19 Targeting Immunotherapy

Tafasitamab - Model MOR208 - Humanized FC-Modified CD19 Targeting Immunotherapy

Manufactured by:MorphoSys AG   based inPlanegg, GERMANY
Tafasitamab (MOR208) is a humanized FC-modified CD19 targeting immunotherapy in clinical development for the treatment of B cell malignancies. CD19 is broadly expressed on the surface of B cells. It is therefore considered as a potential target for the treatment of B cell malignancies, such as non-Hodgkin’s lymphoma (NHL), including diffuse ...
CONTACT SUPPLIER
  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT